-
The costs of hepatitis A infections in South Korea
-
Kyohyun Kim, Baek-Geun Jeong, Moran Ki, Mira Park, Jin Kyung Park, Bo Youl Choi, Weon-Seob Yoo
-
Epidemiol Health. 2014;36:e2014011. Published online August 18, 2014
-
DOI: https://doi.org/10.4178/epih/e2014011
-
-
20,569
View
-
143
Download
-
5
Web of Science
-
6
Crossref
-
 Abstract
 PDF Supplementary Material
-
Abstract
OBJECTIVES
The incidence of hepatitis A infections among young adults has recently increased in South Korea. Although universal vaccination has often been suggested to mitigate the problem, its rationale has not been well-understood. Estimating the societal costs of hepatitis A infections might support the development of intervention strategies.
METHODS We classified hepatitis A infections into eight clinical pathways and estimated the number of occurrences and cost per case for each clinical pathway using claim data from National Health Insurance and several national surveys as well as assumptions based on previous studies. To determine the total costs of a hepatitis A infection, both direct and indirect costs were estimated. Indirect costs were estimated using the human-capital approach. All costs are adjusted to the year 2008.
RESULTS There were 30,240 identified cases of hepatitis A infections in 2008 for a total cost of 80,873 million won (2.7 million won per case). Direct and indirect costs constituted 56.2% and 43.8% of the total costs, respectively. People aged 20-39 accounted for 71.3% of total cases and 74.6% of total costs. Medical costs per capita were the lowest in the 0-4 age group and highest in the 20-29 age group.
CONCLUSIONS This study could provide evidence for development of cost-effective interventions to control hepatitis A infections. But the true costs including uncaptured and intangible costs of hepatitis A infections might be higher than our results indicate.
-
Summary
-
Citations
Citations to this article as recorded by  - The chronological changes in the seroprevalence of anti-hepatitis A virus IgG from 2005 to 2019: Experience at four centers in the capital area of South Korea
Dae Hyun Lim, Won Sohn, Jae Yoon Jeong, Hyunwoo Oh, Jae Gon Lee, Eileen L. Yoon, Tae Yeob Kim, Seungwoo Nam, Joo Hyun Sohn
Medicine.2022; 101(48): e31639. CrossRef - Perspectives on Acute Hepatitis A Control in Korea
Seong Hee Kang, Moon Young Kim, Soon Koo Baik
Journal of Korean Medical Science.2019;[Epub] CrossRef - Seropositive rate of the anti-hepatitis A immunoglobulin G antibody in maintenance hemodialysis subjects from two hospitals in Korea
Hyunsuk Kim, Jiwon Ryu, Young-Ki Lee, Myung Jin Choi, Ajin Cho, Ja-Ryong Koo, Sae Yun Baik, Eun Hee Lee, Jong-Woo Yoon, Jung-Woo Noh
The Korean Journal of Internal Medicine.2019; 34(6): 1297. CrossRef - Causes and countermeasures for repeated outbreaks of hepatitis A among adults in Korea
Moran Ki, Hyunjin Son, Bo Youl Choi
Epidemiology and Health.2019; 41: e2019038. CrossRef - Estimating the Incidence of Cases and Deaths Resulting from Hand, Foot and Mouth Disease and Its Related Socioeconomic Disease Burden in Republic of Korea (2010 – 2014)
Donghee Seo
Osong Public Health and Research Perspectives.2018; 9(3): 112. CrossRef - Viral Hepatitis in South Korea
Stella C Pak, Yaseen Alastal, Zubair Khan, Umar Darr
Euroasian Journal of Hepato-Gastroenterology.2017; 7(2): 163. CrossRef
|
KSE
